16 Patents
- US125530642026Methods and Compositions for Targeted Genetic Modification Through Single-step Multiple Targeting
Regeneron Pharmaceuticals, Inc.
0 cites - US125290722026Transcription Modulation in Animals Using CRISPR/CAS Systems
Regeneron Pharmaceuticals, Inc.
0 cites - US124215122025Crispr/cas Screening Platform to Identify Genetic Modifiers of Tau Seeding or Aggregation
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US123428012025Methods for Producing Antigen-binding Proteins Against Foreign Antigens
Regeneron Pharmaceuticals, Inc.
0 cites - US123178742025Method of Using a Genetically Modified Mouse That Expresses Human Albumin
REGENERON PHARMACEUTICALS, Inc.
0 cites - US122092382025Crispr/cas Screening Platform to Identify Genetic Modifiers of Tau Seeding or Aggregation
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US118916182024Mouse Comprising a Humanized TTR Locus with a Beta-slip Mutation and Methods of Use
Regeneron Pharmaceuticals, Inc.
0 cites - US118667942024Cas-ready Mouse Embryonic Stem Cells and Mice and Uses Thereof
Regeneron Pharmaceuticals, Inc.
0 cites - US118459312023Crispr/cas Screening Platform to Identify Genetic Modifiers of Tau Seeding or Aggregation
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US117811312023Crispr/cas Dropout Screening Platform to Reveal Genetic Vulnerabilities Associated with Tau Aggregation
Regeneron Pharmaceuticals, Inc.
0 cites - 0 cites
- US116225472023Genetically Modified Mouse That Expresses Human Albumin
Regeneran Pharmaceuticals, Inc.
0 cites